Showing results (1401-1410 of 1,506) with videos related to

Sort By:
Pageof 151
Brain Imaging and Behavior|May 11, 2011
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's diseaseCatherine L Gallagher, Sterling C Johnson, Barbara B Bendlin, et al.
Plos One|August 15, 2009
Genetic variation in healthy oldest-oldJulius Halaschek-Wiener, Mahsa Amirabbasi-Beik, Nasim Monfared, et al.
International Journal of Occupational and Environmental Health|February 18, 2017
Leptospira seropositivity as a risk factor for Mesoamerican NephropathyAlejandro Riefkohl, Oriana Ramírez-Rubio, Rebecca L Laws, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular DysfunctionYasuko Furumoto, Carolyne K Smith, Luz Blanco, et al.
Scientific Reports|November 17, 2022
ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutationAdam Sheriff, Ina Guri, Paulina Zebrowska, et al.
RMD Open|March 29, 2023
Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphismMarta Casal Moura, Zuoming Deng, Stephen R Brooks, et al.
Scandinavian Journal of Work, Environment & Health|May 18, 2021
Dysuria, heat stress, and muscle injury among Nicaraguan sugarcane workers at risk for Mesoamerican nephropathyTiffany L Stallings, Alejandro Riefkohl Lisci, Nathan L McCray, et al.
Immunity|March 3, 2021
MicroRNA-221 and -222 modulate intestinal inflammatory Th17 cell response as negative feedback regulators downstream of interleukin-23Yohei Mikami, Rachael L Philips, Giuseppe Sciumè, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 31, 2016
Characterization of Mesoamerican Nephropathy in a Kidney Failure Hotspot in NicaraguaJoseph Kupferman, Juan José Amador, Katherine E Lynch, et al.
Clinical Pharmacology and Therapeutics|November 15, 2017
Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI PatientsHanna Kim, Kristina M Brooks, Cheng Cai Tang, et al.
Pageof 151